Q2 2023 Holdings
Filed 2023-08-14 | 53 holdings | $4.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $791.0M | 11,584,280 | 19.4% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $496.6M | 5,451,647 | 12.2% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $419.2M | 3,660,798 | 10.3% |
| Johnson & Johnson(JNJ)Call | COM | 478160104 | $281.4M | 1,700,000 | 6.9% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $234.0M | 5,756,268 | 5.7% |
| Morphic Hldg Inc | COM | 61775R105 | $220.5M | 3,846,964 | 5.4% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $192.6M | 7,198,700 | 4.7% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $153.0M | 7,521,024 | 3.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $143.5M | 5,991,479 | 3.5% |
| Xencor Inc(XNCR) | COM | 98401F105 | $131.9M | 5,282,516 | 3.2% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $116.1M | 13,437,473 | 2.8% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $113.7M | 1,798,300 | 2.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $99.7M | 4,017,788 | 2.4% |
| Springworks Therapeutics Inc | COM | 85205L107 | $90.7M | 3,460,208 | 2.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $61.4M | 5,806,871 | 1.5% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $52.3M | 4,163,824 | 1.3% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $45.7M | 368,411 | 1.1% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $44.1M | 3,851,507 | 1.1% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $34.8M | 5,618,779 | 0.9% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $27.1M | 3,493,194 | 0.7% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $26.5M | 3,418,068 | 0.6% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $26.2M | 6,995,861 | 0.6% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $25.0M | 13,896,543 | 0.6% |
| Alector Inc(ALEC) | COM | 014442107 | $24.4M | 4,056,548 | 0.6% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $24.0M | 1,330,263 | 0.6% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $22.3M | 4,488,200 | 0.5% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $22.2M | 8,538,446 | 0.5% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $20.1M | 6,117,400 | 0.5% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $16.7M | 6,435,518 | 0.4% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $13.4M | 4,047,114 | 0.3% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $12.5M | 5,000,000 | 0.3% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $11.3M | 2,046,867 | 0.3% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $10.0M | 2,088,780 | 0.2% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $10.0M | 700,000 | 0.2% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $9.0M | 798,701 | 0.2% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $8.8M | 600,000 | 0.2% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $8.5M | 300,000 | 0.2% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $5.4M | 452,590 | 0.1% |
| Kura Oncology Inc(KURA)Call | COM | 50127T109 | $5.3M | 500,000 | 0.1% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $5.2M | 1,157,452 | 0.1% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $4.8M | 2,980,016 | 0.1% |
| Hookipa Pharma Inc | COM | 43906K100 | $4.0M | 4,595,024 | 0.1% |
| Aligos Therapeutics Inc | COM | 01626L105 | $3.8M | 3,948,360 | 0.1% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $3.3M | 748,900 | 0.1% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $2.3M | 5,000,000 | 0.1% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $1.7M | 963,333 | 0.0% |
| Tempest Therapeutics Inc(OVASUSD) | COM | 87978U108 | $1.4M | 1,123,434 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $1.2M | 66,978 | 0.0% |
| Poseida Therapeutics Inc(PSTXUSD) | COM | 73730P108 | $1.2M | 676,296 | 0.0% |
| Newamsterdam Pharma Company | *W EXP 11/22/202 | N62509117 | $792.6K | 66,665 | 0.0% |